Isoniazid population pharmacokinetics in HIV perinatally exposed infants 

Population pharmacokinetic/pharmacodynamic modeling: evaluation of maximum likelihood expectation maximization method in ADAPT 5 

Pharmacokinetic/pharmacodynamic modeling for genetically polymorphic populations 

Animal to human scaling and pharmacokinetic/pharmacodynamic modeling of anticancer drugs 

In-silico physiological based pharmacokinetic modeling of prodrugs 

A nonlinear pharmacokinetic model used in calibrating a transdermal alcohol transport concentration biosensor data analysis software 

The pharmacokinetics and pharmacodynamics of vincristine in the adolescent and young adult population compared to younger patients 

Nonparametric estimation of an unknown probability distribution using maximum likelihood and Bayesian approaches 

Pharmacokinetics-pharmacodynamics of tedizolid in plasma and sputum of adults with cystic fibrosis 

A hierarchical physiologically-based pharmacokinetic modeling platform for genetic and exposure effects in metabolic pathways 

Image-driven pharmacokinetics of tropoelastin nanoparticles 

Pharmacogenetic association studies and the impact of population substructure in the women's interagency HIV study 

Effects of protease inhibitor use on combined oral contraceptive pharmacokinetics and pharmacodynamics in HIV-positive women 

Pharmacokinetics and pharmacogenomics of once daily raltegravir and atazanavir in healthy volunteers 

The NONMEM approach to estimation of population pharmacokinetic parameters 

Population modeling and Bayesian estimation for the deconvolution of blood alcohol concentration from transdermal alcohol biosensor data 

Ribavirin systemic and intracellular exposure and its role on viral response and anemia in chronic hepatitis C genotype 1 infection 

FDA's Critical Path: Status, Priorities & Models for Collaboration, 2007 

Accelerating the Development of Dynamic Imaging Biomarkers, 2007 

Computational models for drug design and delivery 

Economic Considerations on the Use of Non-Invasive Imaging for Drug Discovery and Drug Monitoring, 2007 

Construction and validation of multivariable population pharmacokinetic models: Utility of allometric forms to predict the pharmacokinetic disposition of gentamicin in pediatric patients with app... 

Physiologically-based modeling to predict monoclonal antibody pharmacokinetics in humans from physiochemical properties 

Therapeutic potential of Rhesus theta defensin-1 for the treatment of COVID-19 pneumonia 

Pharmacokinetics and developmental effects of exposures to selective serotonin reuptake inhibitor (SSRI) antidepressants